NatWest Group upgraded its 2025 guidance after reporting a strong third-quarter profit rise, while GSK secured US approval for its multiple myeloma drug Blenrep. Here is what you need to know before ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback